Chad Pettit

Executive Director, Marketing, Global Biosimilars Commercial Lead at Amgen

Speaker

As Executive Director, Marketing for Amgen’s Biosimilars Business Unit, Chad Pettit leads the Global Biosimilars Commercial Team in developing global launch strategy for Amgen’s portfolio biosimilar medicines. He serves as a liaison with the biopharmaceutical industry on policy matters in biosimilars, a rapidly growing segment of the Amgen business. With his global experience, Chad has broad perspective and is recognized as an expert on biosimilar commercialization, market access for biosimilars, and the policy measures required to facilitate cost savings for patients and the health care system over the long-run.

Chad’s 20 years of experience at Amgen have included service as the Amgen board member of the US Biosimilars Forum industry trade group, and a career focus on pricing, market access, and policy crossing all global regions in a broad range of roles in the US and Europe.

Chad received his MBA from the University of California Los Angeles, Anderson School of Management, and holds a B.S. in Chemical Engineering from the University of California Davis. In his spare time, he provides leadership and service within the community, enjoys the outdoors, and spends time with his wife Amy and four children.